JEDI Pivotal Study Article from the San Diego Business Journal
by Gallant Staff
Read coverage from the San Diego Business Journal about our pivotal study of allogeneic stem cell therapy targeting feline chronic gingivostomatitis (FCGS), a painful and debilitating disease in cats.
From the San Diego Business Journal (requires subscription)
Gallant Advances Stem Cell Therapy for Cats
